{
  "cik": 1549595,
  "cik_padded": "0001549595",
  "entityName": "Nurix Therapeutics, Inc.",
  "fiscal_years": [
    {
      "accn": "0001549595-26-000016",
      "filed": "2026-01-28",
      "fiscal_year": 2025,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 14002000.0,
        "cash": 246960000.0,
        "eps_diluted": -3.05,
        "free_cash_flow": -263467000.0,
        "net_income": -264457000.0,
        "operating_cash_flow": -249465000.0,
        "operating_income": -285666000.0,
        "revenue": 83980000.0,
        "stockholders_equity": 538747000.0,
        "total_assets": 688135000.0,
        "total_liabilities": 149388000.0
      },
      "period_end": "2025-11-30",
      "ratio_units": {
        "leverage": "ratio",
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.27728785496717384,
        "revenue_growth_yoy": 0.5395332636711947,
        "roa_avg2y": -0.3896298871878587,
        "roa_period_end": -0.3843097647990583,
        "roe_avg2y": -0.4962880252219115,
        "roe_period_end": -0.4908741951231283
      }
    },
    {
      "accn": "0001549595-26-000016",
      "filed": "2026-01-28",
      "fiscal_year": 2024,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 9273000.0,
        "cash": 109997000.0,
        "eps_diluted": -2.88,
        "free_cash_flow": -181857000.0,
        "net_income": -193569000.0,
        "operating_cash_flow": -172584000.0,
        "operating_income": -213027000.0,
        "revenue": 54549000.0,
        "stockholders_equity": 526993000.0,
        "total_assets": 669343000.0,
        "total_liabilities": 142350000.0
      },
      "period_end": "2024-11-30",
      "ratio_units": {
        "leverage": "ratio",
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.2701174398900934,
        "revenue_growth_yoy": -0.2914518035512489,
        "roa_avg2y": -0.3777173515353567,
        "roa_period_end": -0.28919253656197197,
        "roe_avg2y": -0.5321586944628488,
        "roe_period_end": -0.36730848417341405
      }
    },
    {
      "accn": "0001549595-26-000016",
      "filed": "2026-01-28",
      "fiscal_year": 2023,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 8401000.0,
        "cash": 54627000.0,
        "eps_diluted": -2.65,
        "free_cash_flow": -89766000.0,
        "net_income": -143948000.0,
        "operating_cash_flow": -81365000.0,
        "operating_income": -155063000.0,
        "revenue": 76987000.0,
        "stockholders_equity": 200493000.0,
        "total_assets": 355598000.0,
        "total_liabilities": 155105000.0
      },
      "period_end": "2023-11-30",
      "ratio_units": {
        "leverage": "ratio",
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.7736180315522238,
        "revenue_growth_yoy": 0.9930877365573304,
        "roa_avg2y": -0.3727499071025446,
        "roa_period_end": -0.40480542635222927,
        "roe_avg2y": -0.5710080941869021,
        "roe_period_end": -0.7179702034484996
      }
    },
    {
      "accn": "0001549595-26-000016",
      "filed": "2026-01-28",
      "fiscal_year": 2022,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 12244000.0,
        "cash": 64474000.0,
        "eps_diluted": -3.71,
        "free_cash_flow": -172051000.0,
        "net_income": -180360000.0,
        "operating_cash_flow": -159807000.0,
        "operating_income": -183867000.0,
        "revenue": 38627000.0,
        "stockholders_equity": 303696000.0,
        "total_assets": 416759000.0,
        "total_liabilities": 113063000.0
      },
      "period_end": "2022-11-30",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.37229005321110586,
        "roa_avg2y": -0.40370217004465436,
        "roa_period_end": -0.4327680985893526,
        "roe_avg2y": -0.5583918216465067,
        "roe_period_end": -0.5938833570412517
      }
    },
    {
      "accn": "0001549595-25-000016",
      "filed": "2025-01-28",
      "fiscal_year": 2021,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 5661000.0,
        "cash": 80506000.0,
        "eps_diluted": -2.73,
        "free_cash_flow": -90026000.0,
        "net_income": -117194000.0,
        "operating_cash_flow": -84365000.0,
        "operating_income": -117886000.0,
        "stockholders_equity": 342302000.0,
        "total_assets": 476771000.0,
        "total_liabilities": 134469000.0
      },
      "period_end": "2021-11-30",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.39283731909249725,
        "roa_avg2y": -0.2684506261496208,
        "roa_period_end": -0.24580773578929926,
        "roe_avg2y": -0.37053231969217687,
        "roe_period_end": -0.3423701877289645
      }
    },
    {
      "accn": "0001564590-22-003007",
      "filed": "2023-02-09",
      "fiscal_year": 2020,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 4553000.0,
        "cash": 119356000.0,
        "free_cash_flow": -4633000.0,
        "net_income": -43242000.0,
        "operating_cash_flow": -80000.0,
        "operating_income": -64983000.0,
        "stockholders_equity": 290269000.0,
        "total_assets": 396343000.0,
        "total_liabilities": 106074000.0
      },
      "period_end": "2020-11-30",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.36543344277204937,
        "roa_avg2y": -0.19638003501433954,
        "roa_period_end": -0.10910246932581122,
        "roe_avg2y": -0.3718862204639763,
        "roe_period_end": -0.14897216030647434
      }
    },
    {
      "accn": "0001564590-22-003007",
      "filed": "2022-01-28",
      "fiscal_year": 2019,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 1651000.0,
        "cash": 34816000.0,
        "free_cash_flow": -1050000.0,
        "net_income": -21699000.0,
        "operating_cash_flow": 601000.0,
        "operating_income": -22236000.0,
        "stockholders_equity": -57714000.0,
        "total_assets": 44048000.0,
        "total_liabilities": 53567000.0
      },
      "period_end": "2019-11-30",
      "ratio_units": {
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio"
      },
      "ratios": {
        "roa_period_end": -0.4926216854340719,
        "roe_avg2y": 0.45894184706168506
      }
    },
    {
      "accn": "0001564590-22-003007",
      "filed": "2022-01-28",
      "fiscal_year": 2018,
      "form": "10-K",
      "fundamental_units": {
        "stockholders_equity": "USD"
      },
      "fundamentals": {
        "stockholders_equity": -36847000.0
      },
      "period_end": "2018-11-30",
      "ratios": {}
    }
  ],
  "latest_filing": {
    "accn": "0001549595-26-000016",
    "filed": "2026-01-28",
    "form": "10-K"
  },
  "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.",
  "schema_version": "1",
  "sic": "2834",
  "sic_description": "Pharmaceutical Preparations",
  "source_urls": {
    "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001549595.json",
    "sec_submissions": "https://data.sec.gov/submissions/CIK0001549595.json"
  },
  "ticker": "NRIX"
}